Latest News and Press Releases
Want to stay updated on the latest news?
-
Worldwide sales of $34.1 million reflects growth of 17.5% U.S. Essure® sales grow 22.2% Adjusted EBITDA reaches $7.7 million MOUNTAIN VIEW, Calif., April 29, 2013 (GLOBE...
-
MOUNTAIN VIEW, Calif. and LEVERKUSEN, Germany, April 29, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading surgery-free permanent birth...
-
MOUNTAIN VIEW, Calif., April 9, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading non-surgical permanent birth control method, today...
-
MOUNTAIN VIEW, Calif., Feb. 27, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading surgery-free permanent birth control method, announced...
-
MOUNTAIN VIEW, Calif., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading surgery-free permanent birth control method, announced today...
-
New ACOG Practice Bulletin Highlights Hysteroscopic Sterilization for the First Time Record sales of $40.7 million reflects growth of 21.5%; 23.6% constant currency Essure only Record U.S....
-
MOUNTAIN VIEW, Calif., Jan. 22, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading surgery-free permanent birth control method, announced...
-
MOUNTAIN VIEW, Calif., Jan. 8, 2013 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading non-surgical permanent birth control method, today announced...
-
MOUNTAIN VIEW, Calif., Dec. 26, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading surgery-free permanent birth control method, announced...
-
MOUNTAIN VIEW, Calif., Nov. 14, 2012 (GLOBE NEWSWIRE) -- In a release issued earlier today by Conceptus, Inc. (Nasdaq:CPTS), the date for the UNCAM decision to be effective was incorrect in the...